SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

We are hiring

Current vacancies

Research Associate - Viral Vectors

Click here for more details

Research Associate - Protein Production

Click here for more details